Adjuvant Endocrine Therapy for Premenopausal Women With Early Breast Cancer

This publication has 79 references indexed in Scilit:

• Prevention of breast cancer in women who carry BRCA1 or BRCA2 mutations: A critical review of the literature
  International Journal of Cancer, 2004
• A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer
  New England Journal of Medicine, 2004
• A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer
  New England Journal of Medicine, 2003
• Survival analyses from the ZEBRA study
  European Journal of Cancer, 2003
• Tamoxifen in high-risk premenopausal women with primary breast cancer receiving adjuvant chemotherapy. Report from the Danish Breast Cancer Co-operative Group DBCG 82B trial
  European Journal of Cancer, 1999
• Polychemotherapy for early breast cancer: an overview of the randomised trials
  The Lancet, 1998
• PP-5-6 Castration and Tamoxifen Versus Chemotherapy (FAC) for Premenopausal, Node and Receptors Positive Breast Cancer Patients: A Randomized Trial with a 7 Years Median Follow Up
  European Journal of Cancer, 1996
• Tamoxifen resistance in breast cancer
  Critical Reviews in Oncology/Hematology, 1993
• A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive Tumors
  New England Journal of Medicine, 1989
• ON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.1
  The Lancet, 1896